Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Raquel Cid, Jorge Bolı́var
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1072-1072
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis
Pathogens (2023) Vol. 12, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 49
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
Bowen Lu, Jing Ming Lim, Boyue Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 32
In silico design of a novel multi-epitope vaccine against HCV infection through immunoinformatics approaches
Sajjad Ahmad, Fatemeh Mobini Demneh, Bushra Rehman, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131517-131517
Closed Access | Times Cited: 20
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 14
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
Ziqi Wang, Kai Cui, Ulrich Costabel, et al.
Exploration (2022) Vol. 2, Iss. 5
Open Access | Times Cited: 41
Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward
Ganesh Kumraj, Sarang Pathak, Sanket Shah, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 36
Developments in Rabies Vaccines: The Path Traversed from Pasteur to the Modern Era of Immunization
Krithiga Natesan, Shrikrishna Isloor, V. Balamurugan, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 756-756
Open Access | Times Cited: 24
An In Silico Multi-epitopes Vaccine Ensemble and Characterization Against Nosocomial Proteus penneri
Asad Ullah, Bushra Rehman, Saifullah Khan, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 12, pp. 3498-3513
Closed Access | Times Cited: 24
Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge
Ding Tang, Xiaoke Liu, Jia Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine
Eddie Underwood, Lisa M. Dunkle, Shabir A. Madhi, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 501-517
Open Access | Times Cited: 21
Pivotal role of Helicobacter pylori virulence genes in pathogenicity and vaccine development
Ayman Elbehiry, Eman Marzouk, Adil Abalkhail, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
COVID-19: The vaccine development strategies
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 645-667
Closed Access
Live Plague Vaccine Development: Past, Present, and Future
Andrey P. Anisimov, A. S. Vagaiskaya, A. S. Trunyakova, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 66-66
Open Access
Rabies Vaccines: Journey from Classical to Modern Era
Bushra Khan, Nidhi Shrivastava, Naseer Sheikh, et al.
Veterinary Vaccine (2025), pp. 100105-100105
Open Access
Advancements in Protein-Based Bionanocomposites for Targeted and Controlled Drug Delivery Systems: A Comprehensive Review
Dahlang Tahir, Syarifuddin Syarifuddin, E Noor, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106698-106698
Closed Access
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies
Frances Rocamora, Angelo G. Peralta, Seunghyeon Shin, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108206-108206
Open Access | Times Cited: 19
Therapeutic Protein-Based Vaccines
Shaban Ahmad, Vandana Dahiya, Arpana Vibhuti, et al.
(2023), pp. 355-384
Closed Access | Times Cited: 15
Animal Cell Lines as Expression Platforms in Viral Vaccine Production: A Post Covid-19 Perspective
S. Furkan Demirden, Ilgin Kimiz‐Gebologlu, Suphi Ş. Öncel
ACS Omega (2024)
Open Access | Times Cited: 5
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 4
Diverting organic waste from landfills via insect biomanufacturing using engineered black soldier flies (Hermetia illucens)
Kate Tepper, Owain R. Edwards, Anwar Sunna, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 4
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
Anirudha Chattopadhyay, A. Abdul Kader Jailani, Bikash Mandal
Vaccines (2023) Vol. 11, Iss. 8, pp. 1347-1347
Open Access | Times Cited: 11
Commercial vaccines used in poultry, cattle, and aquaculture: a multidirectional comparison
Anibal Domínguez Odio, Ernesto Rodríguez Martínez, Daniel Leonardo Cala Delgado
Frontiers in Veterinary Science (2024) Vol. 10
Open Access | Times Cited: 4
CHO cells for virus-like particle and subunit vaccine manufacturing
Zalma V. Sanchez-Martinez, Sergio P. Alpuche-Lazcano, Matthew Stuible, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2530-2542
Open Access | Times Cited: 3
Vaccine design and development: Exploring the interface with computational biology and AI
Ananya Ananya, Darshan C. Panchariya, Anandakrishnan Karthic, et al.
International Reviews of Immunology (2024) Vol. 43, Iss. 6, pp. 361-380
Closed Access | Times Cited: 3
Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development
Xintao Hu, Hsuan-Yuan Wang, Claire E. Otero, et al.
Annual Review of Virology (2022) Vol. 9, Iss. 1, pp. 491-520
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top